Dr. Naiem Issa discusses his article published in JCAD January 2025, titled “Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series.”
Reference:
Dr. Graber discusses her article published in JCAD January 2025, titled “Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel plus Clascoterone 1% Cream in Adult Patients with Acne.” Reference:
...
Dr. Nada Elbuluk discusses her article published in JCAD January 2025, titled “Utilization of Internet and Social Media by Outpatient Dermatology Patients: A Prospective, Cross-sectional Study.” Reference:
...
Tina Bhutani, MD, discusses a new article published in the October 2024 issue of JCAD that describes patient-reported symptoms and treatment satisfaction in patients with moderate-to-severe plaque psoriasis treated with tildrakizumab 100mg over 64 weeks. Read full article here Reference:
...
Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic arthritis symptom onset and diagnosis to the likelihood and severity of depression, social impairment, and disease impact on quality of life. Read full article here Reference:
...
James Del Rosso, DO, Clinical Editor-in-Chief of JCAD, discusses a new review article published in the August 2024 issue of JCAD, titled “Clindamycin: A Comprehensive Status Report with Emphasis on Use in Dermatology.” Reference: Del Rosso J, Armillei MK, Lomakin IB, Grada A, Bunick CG. Clindamycin: A Comprehensive Status Report with Emphasis on Use in […]
...
